JN403, a nicotinic acetylcholine receptor alpha 7 selective agonist: Structure-activity relationship and in vitro and in vivo profile

被引：0
|
作者：
Nozulak, J. [1 ]
Feuerbach, D. [1 ]
Hoyer, D. [1 ]
Lingenhoehl, K. [1 ]
Olpe, H. -R. [1 ]
Vassout, A. [1 ]
Gentsch, C. [1 ]
Chaperon, F. [1 ]
McAllister, K. [1 ]
机构：
[1] Novartis Pharma AG, GDC Neurosci, Basel, Switzerland
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：265 / 266
页数：2
相关论文
共 50 条
  • [1] JN403, in vitro characterization of a novel nicotinic acetylcholine receptor α7 selective agonist
    Feuerbach, Dominik
    Nozulak, Joachim
    Lingenhoehl, Kurt
    McAllister, Kevin
    Hoyer, Daniel
    NEUROSCIENCE LETTERS, 2007, 416 (01) : 61 - 65
  • [2] Structure activity relationship, in vitro and in vivo profile of JN403, a nAChR a7 selective agonist
    Nozulak, Joachim
    Hoyer, Daniel
    Chaperon, Frederique
    Lingenhoehl, Kurt
    Vassout, Annick
    Feuerbach, Dominik
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [3] Concise Synthesis of JN403, a Novel Nicotinic Acetylcholine Receptor 7 Selective Agonist
    Jiang, Xinglong
    Prasad, Kapa
    Repic, Oljan
    SYNTHETIC COMMUNICATIONS, 2009, 39 (15) : 2640 - 2646
  • [4] The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain
    Feuerbach, Dominik
    Lingenhoehl, Kurt
    Olpe, Hans-Rudolf
    Vassout, Annick
    Gentsch, Conrad
    Chaperon, Frederique
    Nozulak, Joachim
    Enz, Albert
    Bilbe, Graeme
    McAllister, Kevin
    Hoyer, Daniel
    NEUROPHARMACOLOGY, 2009, 56 (01) : 254 - 263
  • [5] Different Interaction between the Agonist JN403 and the Competitive Antagonist Methyllycaconitine with the Human α7 Nicotinic Acetylcholine Receptor
    Arias, Hugo R.
    Gu, Ruo-Xu
    Feuerbach, Dominik
    Wei, Dong-Qing
    BIOCHEMISTRY, 2010, 49 (19) : 4169 - 4180
  • [6] Differential Pharmacological Activity of JN403 between α7 and Muscle Nicotinic Acetylcholine Receptors
    Arias, Hugo R.
    Jose De Rosa, Maria
    Berge, Ignacio
    Feuerbach, Dominik
    Bouzat, Cecilia
    BIOCHEMISTRY, 2013, 52 (47) : 8480 - 8488
  • [7] Effects of JN403, an α-7-nicotine-acetylcholine-receptor (α7-nAChR) agonist on human alpha-synuclein-mediated in vitro and in vivo models of Parkinson's disease
    Lee, B.
    Noelker, C.
    Chiu, W.
    Feuerbach, D.
    Timmerman, L.
    Oertel, W.
    MOVEMENT DISORDERS, 2018, 33 : S168 - S169
  • [8] Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as α7 nicotinic acetylcholine receptor agonists
    Walker, Daniel P.
    Wishka, Donn G.
    Piotrowski, David W.
    Jia, Shaojuan
    Reitz, Steven C.
    Yates, Karen M.
    Myers, Jason K.
    Vetman, Tatiana N.
    Margolis, Brandon J.
    Jacobsen, E. Jon
    Acker, Brad A.
    Groppi, Vincent E.
    Wolfe, Mark L.
    Thornburgh, Bruce A.
    Tinholt, Paula M.
    Cortes-Burgos, Luz A.
    Walters, Rodney R.
    Hester, Matthew R.
    Seest, Eric P.
    Dolak, Lester A.
    Han, Fusen
    Olson, Barbara A.
    Fitzgerald, Laura
    Staton, Brian A.
    Raub, Thomas J.
    Hajos, Mihaly
    Hoffmann, William E.
    Li, Kai S.
    Higdon, Nicole R.
    Wall, Theron M.
    Hurst, Raymond S.
    Wong, Erik H. F.
    Rogers, Bruce N.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (24) : 8219 - 8248
  • [9] Structure-activity relationships in a peptidic α7 nicotinic acetylcholine receptor antagonist
    Rogers, JP
    Luginbühl, P
    Pemberton, K
    Harty, P
    Wemmer, DE
    Stevens, RC
    JOURNAL OF MOLECULAR BIOLOGY, 2000, 304 (05) : 911 - 926
  • [10] Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor
    Lee, J
    Davis, CB
    Rivero, RA
    Reitz, AB
    Shank, RP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (10) : 1063 - 1066
12345